| 1 |
Reyes J, Yap GS. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis. J Immunol 2023;210:5-11. [PMID: 36542831 DOI: 10.4049/jimmunol.2200641] [Reference Citation Analysis]
|
| 2 |
Hasankhani A, Bahrami A, Tavakoli-Far B, Iranshahi S, Ghaemi F, Akbarizadeh MR, Amin AH, Abedi Kiasari B, Mohammadzadeh Shabestari A. The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy. Front Immunol 2023;14:1127358. [PMID: 36875108 DOI: 10.3389/fimmu.2023.1127358] [Reference Citation Analysis]
|
| 3 |
Galassi A, Ciceri P, Bono V, Magagnoli L, Sala M, Artioli L, Rovito R, Hadla M, Yellenki V, D'Arminio Monforte A, Tincati C, Cozzolino M, Marchetti G. Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19. Biomedicines 2022;10. [PMID: 36552007 DOI: 10.3390/biomedicines10123251] [Reference Citation Analysis]
|
| 4 |
Hamza AM, Ali WDK, Hassanein N, Albassam WB, Barry M, AlFaifi AMM, Altayyar KAS, Aboabat NAM, Alshaiddi WKF, AbuSabbah HMH, Alamri AH, Albabtain SAH, Alsayed E. Relation between macrophage inflammatory protein-1 and intercellular adhesion molecule-1 and computed tomography findings in critically-ill saudi covid-19 patients. J Infect Public Health 2022;15:1497-502. [PMID: 36423464 DOI: 10.1016/j.jiph.2022.10.023] [Reference Citation Analysis]
|
| 5 |
Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 6 |
Royston L, Isnard S, Perrin N, Sinyavskaya L, Berini C, Lin J, Trottier B, Baril J, Chartrand-lefebvre C, Tremblay C, Durand M, Routy J. Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.964650] [Reference Citation Analysis]
|
| 7 |
Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier JM, Saad HM, Batiha GE. The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not? Diagnostics (Basel) 2022;12:2051. [PMID: 36140453 DOI: 10.3390/diagnostics12092051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Torrens-mas M, Perelló-reus CM, Trias-ferrer N, Ibargüen-gonzález L, Crespí C, Galmes-panades AM, Navas-enamorado C, Sanchez-polo A, Piérola-lopetegui J, Masmiquel L, Crespi LS, Barcelo C, Gonzalez-freire M. GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Front Cell Infect Microbiol 2022;12:942951. [DOI: 10.3389/fcimb.2022.942951] [Reference Citation Analysis]
|
| 9 |
Watkins RR. Using Precision Medicine for the Diagnosis and Treatment of Viral Pneumonia. Adv Ther 2022. [PMID: 35596912 DOI: 10.1007/s12325-022-02180-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Torrens-mas M, Perelló-reus CM, Trias-ferrer N, Ibargüen-gonzález L, Crespí C, Galmes-panades AM, Navas-enamorado C, Sanchez-polo A, Piérola-lopetegui J, Masmiquel L, Crespi LS, Barcelo C, Gonzalez-freire M. GDF15 and ACE2 stratify COVID19 patients according to severity while ACE2 mutations increase infection susceptibility.. [DOI: 10.1101/2022.05.06.490907] [Reference Citation Analysis]
|
